Loading organizations...
Loading organizations...
Biopharmaceutical company developing anti-cancer immunotherapies.
MabVax Therapeutics has raised $19.0M across 3 funding rounds.
MabVax Therapeutics has raised $19.0M in total across 3 funding rounds.
MabVax Therapeutics has raised $19.0M in total across 3 funding rounds.
MabVax Therapeutics's investors include Phillip Frost, National Institutes of Health, Numoda Capital Innovations, Burrill Capital Fund IV, RTP Ventures.
MabVax Therapeutics has raised $19.0M across 3 funding rounds. Most recently, it raised $12.0M Other Equity in April 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 8, 2015 | $12.0M Other Equity | Phillip Frost | |
| Sep 24, 2013 | $1.8M Grant | National Institutes of Health | |
| Nov 20, 2012 | $5.3M Series B | Numoda Capital Innovations | Burrill Capital Fund IV, RTP Ventures |